[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$70share](/topic/$70share) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$BMNR closed XXXXX (-2.41%) vol 38.95M. The recent share sale at US$70/share underscores investor confidence; crypto-treasury size now rivals the biggest players and unlocks optionality for staking/yield. Strategy postedclick to access full layout:" [X Link](https://x.com/JS_stockwatch/status/1979703975621652613) [@JS_stockwatch](/creator/x/JS_stockwatch) 2025-10-19T00:19Z XXX followers, XX engagements "Danish financial media outlet konomisk Ugebrev has written an excellent deep dive on $PFE s $70/share acquisition of U.S. obesity biotech Metsera revealing just how intense the bidding war was. According to Metseras SEC filing six major pharma companies - including Pfizer and likely rivals such as $NVO or $LLY - were involved. Pfizer ultimately secured the deal with an offer of $XXXXX in cash plus $XXXXX in milestone payments narrowly beating a rival bid of $87/share that fell apart due to regulatory hurdles. Metseras amylin-based obesity candidates (MET-097i and MET-233i) have significant" [X Link](https://x.com/investseekers/status/1979139576586276948) [@investseekers](/creator/x/investseekers) 2025-10-17T10:57Z 4119 followers, 1381 engagements "@CryptoMilox Confirmed: Reuters reports Brighthouse Financial in talks with Sixth Street for sale at $55/share (14% premium to recent close) valuing it at $3.14B. Prior Aquarian bid ($70/share) was rejected. Deal not assured. $BHF $TSLX" [X Link](https://x.com/grok/status/1978873257056203169) [@grok](/creator/x/grok) 2025-10-16T17:18Z 6.5M followers, XXX engagements "$PYPL is one of the most overlooked names in the market right now. Obvious buy under $70/share. PayPal goes to $100+ easily" [X Link](https://x.com/Julian_Trades1/status/1978803153580740884) [@Julian_Trades1](/creator/x/Julian_Trades1) 2025-10-16T12:40Z XXX followers, 3659 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$BMNR closed XXXXX (-2.41%) vol 38.95M. The recent share sale at US$70/share underscores investor confidence; crypto-treasury size now rivals the biggest players and unlocks optionality for staking/yield. Strategy postedclick to access full layout:"
X Link @JS_stockwatch 2025-10-19T00:19Z XXX followers, XX engagements
"Danish financial media outlet konomisk Ugebrev has written an excellent deep dive on $PFE s $70/share acquisition of U.S. obesity biotech Metsera revealing just how intense the bidding war was. According to Metseras SEC filing six major pharma companies - including Pfizer and likely rivals such as $NVO or $LLY - were involved. Pfizer ultimately secured the deal with an offer of $XXXXX in cash plus $XXXXX in milestone payments narrowly beating a rival bid of $87/share that fell apart due to regulatory hurdles. Metseras amylin-based obesity candidates (MET-097i and MET-233i) have significant"
X Link @investseekers 2025-10-17T10:57Z 4119 followers, 1381 engagements
"@CryptoMilox Confirmed: Reuters reports Brighthouse Financial in talks with Sixth Street for sale at $55/share (14% premium to recent close) valuing it at $3.14B. Prior Aquarian bid ($70/share) was rejected. Deal not assured. $BHF $TSLX"
X Link @grok 2025-10-16T17:18Z 6.5M followers, XXX engagements
"$PYPL is one of the most overlooked names in the market right now. Obvious buy under $70/share. PayPal goes to $100+ easily"
X Link @Julian_Trades1 2025-10-16T12:40Z XXX followers, 3659 engagements
/topic/$70share/posts